These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

776 related items for PubMed ID: 28830842

  • 1. Clinical, epidemiological and microbiological characteristics of relapse and re-infection in Clostridium difficile infection.
    Gómez S, Chaves F, Orellana MA.
    Anaerobe; 2017 Dec; 48():147-151. PubMed ID: 28830842
    [Abstract] [Full Text] [Related]

  • 2. Whole-genome sequencing improves discrimination of relapse from reinfection and identifies transmission events among patients with recurrent Clostridium difficile infections.
    Mac Aogáin M, Moloney G, Kilkenny S, Kelleher M, Kelleghan M, Boyle B, Rogers TR.
    J Hosp Infect; 2015 Jun; 90(2):108-16. PubMed ID: 25935700
    [Abstract] [Full Text] [Related]

  • 3. Clostridium difficile recurrences in Stockholm.
    Sandell S, Rashid MU, Jorup-Rönström C, Ellström K, Nord CE, Weintraub A.
    Anaerobe; 2016 Apr; 38():97-102. PubMed ID: 26802875
    [Abstract] [Full Text] [Related]

  • 4. High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates.
    Tijerina-Rodríguez L, Villarreal-Treviño L, Baines SD, Morfín-Otero R, Camacho-Ortíz A, Flores-Treviño S, Maldonado-Garza H, Rodríguez-Noriega E, Garza-González E.
    PLoS One; 2019 Apr; 14(7):e0220671. PubMed ID: 31365590
    [Abstract] [Full Text] [Related]

  • 5. An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.
    Bouza E, Alcalá L, Marín M, Valerio M, Reigadas E, Muñoz P, González-Del Vecchio M, de Egea V.
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1777-1786. PubMed ID: 28501926
    [Abstract] [Full Text] [Related]

  • 6. Outcome of relapsing Clostridium difficile infections do not correlate with virulence-, spore- and vegetative cell-associated phenotypes.
    Plaza-Garrido Á, Miranda-Cárdenas C, Castro-Córdova P, Olguín-Araneda V, Cofré-Araneda G, Hernández-Rocha C, Carman R, Ibáñez P, Fawley WN, Wilcox MH, Gil F, Calderón IL, Fuentes JA, Guzmán-Durán AM, Alvarez-Lobos M, Paredes-Sabja D.
    Anaerobe; 2015 Dec; 36():30-8. PubMed ID: 26403333
    [Abstract] [Full Text] [Related]

  • 7. Molecular characteristics of Clostridium difficile strains from patients with a first recurrence more than 8 weeks after the primary infection.
    Chen Y, Rashid MU, Huang H, Fang H, Nord CE, Wang M, Weintraub A.
    J Microbiol Immunol Infect; 2017 Aug; 50(4):532-536. PubMed ID: 26698688
    [Abstract] [Full Text] [Related]

  • 8. Genomic and phenotypic diversity of Clostridium difficile during long-term sequential recurrences of infection.
    Sachsenheimer FE, Yang I, Zimmermann O, Wrede C, Müller LV, Gunka K, Groß U, Suerbaum S.
    Int J Med Microbiol; 2018 Apr; 308(3):364-377. PubMed ID: 29490877
    [Abstract] [Full Text] [Related]

  • 9. Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics.
    van Beurden YH, Nezami S, Mulder CJJ, Vandenbroucke-Grauls CMJE.
    Clin Microbiol Infect; 2018 Jan; 24(1):85.e1-85.e4. PubMed ID: 28782647
    [Abstract] [Full Text] [Related]

  • 10. Determining the cause of recurrent Clostridium difficile infection using whole genome sequencing.
    Sim JH, Truong C, Minot SS, Greenfield N, Budvytiene I, Lohith A, Anikst V, Pourmand N, Banaei N.
    Diagn Microbiol Infect Dis; 2017 Jan; 87(1):11-16. PubMed ID: 27771207
    [Abstract] [Full Text] [Related]

  • 11. Epidemiology of Clostridium difficile infection in hospitalized adults and the first isolation of C. difficile PCR ribotype 027 in central China.
    Zhou Y, Mao L, Yu J, Lin Q, Luo Y, Zhu X, Sun Z.
    BMC Infect Dis; 2019 Mar 07; 19(1):232. PubMed ID: 30845918
    [Abstract] [Full Text] [Related]

  • 12. Clostridium difficile isolated from faecal samples in patients with ulcerative colitis.
    Shoaei P, Shojaei H, Jalali M, Khorvash F, Hosseini SM, Ataei B, Vakili B, Ebrahimi F, Tavakoli H, Esfandiari Z, Weese JS.
    BMC Infect Dis; 2019 Apr 30; 19(1):361. PubMed ID: 31039738
    [Abstract] [Full Text] [Related]

  • 13. Comparison of Clostridium difficile isolates from individuals with recurrent and single episode of infection.
    Richardson C, Kim P, Lee C, Bersenas A, Weese JS.
    Anaerobe; 2015 Jun 30; 33():105-8. PubMed ID: 25769665
    [Abstract] [Full Text] [Related]

  • 14. An in silico evaluation of treatment regimens for recurrent Clostridium difficile infection.
    Blanco N, Foxman B, Malani AN, Zhang M, Walk S, Rickard AH, Eisenberg MC.
    PLoS One; 2017 Jun 30; 12(8):e0182815. PubMed ID: 28800598
    [Abstract] [Full Text] [Related]

  • 15. Recurrence of Clostridium difficile infection in the Western Australian population.
    Alfayyadh M, Collins DA, Tempone S, McCann R, Armstrong PK, Riley TV, Cook A.
    Epidemiol Infect; 2019 Jan 30; 147():e153. PubMed ID: 31063109
    [Abstract] [Full Text] [Related]

  • 16. Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin.
    Figueroa I, Johnson S, Sambol SP, Goldstein EJ, Citron DM, Gerding DN.
    Clin Infect Dis; 2012 Aug 30; 55 Suppl 2(Suppl 2):S104-9. PubMed ID: 22752857
    [Abstract] [Full Text] [Related]

  • 17. Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes.
    Falcone M, Tiseo G, Iraci F, Raponi G, Goldoni P, Delle Rose D, Santino I, Carfagna P, Murri R, Fantoni M, Fontana C, Sanguinetti M, Farcomeni A, Antonelli G, Aceti A, Mastroianni C, Andreoni M, Cauda R, Petrosillo N, Venditti M.
    Clin Microbiol Infect; 2019 Apr 30; 25(4):474-480. PubMed ID: 29964230
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of healthcare exposure with acquisition of different Clostridium difficile strain types in patients with recurrent infection or colonization after clinical resolution of initial infection.
    Thabit AK, Housman ST, Burnham CD, Nicolau DP.
    J Hosp Infect; 2016 Feb 30; 92(2):167-72. PubMed ID: 26792686
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.